ArticleOncology letters2022

Immunoexpression of p62/SQSTM1/Sequestosome-1 in human primary and recurrent IDH1/2 wild-type glioblastoma: A pilot study.

Antonio Ieni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.